Cover
Cover | May 13, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 13, 2021 |
Entity Registrant Name | Finch Therapeutics Group, Inc. |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001733257 |
Entity File Number | 001-40227 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 82-3433558 |
Entity Address Address Line1 | 200 Inner Belt Road |
Entity Address, Address Line Two | Suite 400 |
Entity Address City Or Town | Somerville |
Entity Address State Or Province | MA |
Entity Address Postal Zip Code | 02143 |
City Area Code | 617 |
Local Phone Number | 229-6499 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | FNCH |
Security Exchange Name | NASDAQ |